Dialysis-Related Amyloidosis Treatment Act of 2020
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 23, 2020)
Dialysis-Related Amyloidosis Treatment Act of 2020
This bill provides for Medicare coverage and payment of treatments for dialysis-related amyloidosis (a complication of kidney failure that can occur as a result of long-term dialysis).
What just happenedOct 23, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Who’s behind it
- Introduced in HouseOct 23, 2020
- Oct 23, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Oct 23, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Oct 23, 2020IntroReferralIntro-H
Introduced in House
- Oct 23, 2020IntroReferral1000
Introduced in House